8
98 H. Paran et al.
correlates well with the human disease. It is dose-
dependent and has good reproducibility, but is time
consuming and quite complicated (16).
pancreatitis: an experimental model. Dig Dis Sci 1974;
9: 1143–1147.
. Becker V. Pathological anatomy and pathogenesis of
acute pancreatitis. World J Surg 1981; 5: 303–313.
. Blamey SL, Imrie CW, O’Neal J, Gilmour WH, Carter
DC. Prognostic factors in acute pancreatitis. Gut 1984;
25: 1340–1346.
. Hadas N, Orda R, Orda S, Bawnik JB, Wiznitzer T.
Experimental pancreatitis in rats caused by intrapar-
enchymal injection of sodium taurocholate. Isr J Med
Sci 1983; 19: 194–197.
6. Heath DL, Cruickshank DH, Gudgeon M, et al. Role of
Interleukin-6 in mediating the acute phase protein
response and potential as an early means of severity
assessment in acute pancreatitis. Pancreas 1993; 66: 41–
1
3
4
We developed a simple model of injections of
sodium taurocholic acid, at different concentrations,
directly into several sites of the pancreatic parenchyma.
The technique is easy, is highly reproducible, and
results in a macroscopically homogeneous injury to the
pancreas, with dose-dependent acinar necrosis and
dose-dependent moderate mortality. This dose-depen-
dent damage is useful as the same model can be used to
study the mild as well as the fatal necrotising form of
the disease, by increasing the concentration of tauro-
cholate, up to the desired degree of damage. The
sodium taurocholate causes a detergent effect, with
diffuse pancreatic necrosis. The early and late histo-
pathological picture mimics the findings in human
disease.
Intraparenchymal injection of sodium taurocholate
resulted in a substantial early increase in plasma
activities of lipase, amylase, and LDH. The increase in
enzyme values seen in the controls probably resulted
from the manual handling and puncture of the gland,
but did not result in any discernible late damage. It is
important to stress, however, that in the clinical
setting, amylase and lipase are not considered to be
of prognostic significance, and are useful only as
markers of the diagnosis of pancreatitis. The increase
in these enzymes comes early in the course of the
pancreatitis and does not correlate with the amount of
damage to the gland or the outcome of the disease
5
4
5.
7
8
9
. Inagaki T, Hoshino M, Hayakawa T, et al. Interleukin 6
is a useful marker for early prediction of the severity of
acute pancreatitis. Pancreas 1997; 14: 1–8.
. Kaplan O, Kaplan D, Kasif E, et al. Effect of delayed
octreotide treatment in acute experimental pancreatitis
in rats. J Surg Res 1996; 62: 109–117.
. Kaplan O, Kushnir T, Sandbank U, Navon G. Acute
pancreatitis in rats: a 31P nuclear magnetic reasonance
study. J Surg Res 1987; 43: 172–178.
0. Lampel M, Kern Hf. Acute interstitial pancreatitis in the
rat induced by excessive doses of a pancreatic
secretagogue. Virchows Arch 1977; 373: 97–117.
1. Moscovitz H, Shofer F, Mignott H, Behrman A,
Kilpatrick L. Plasma cytokine determinations in emer-
gency department patients as a predictor of bacteremia
and infectious diseases severity. Crit Care Med 1994;
1
1
2
2: 1102–1107.
1
2. Norman J, Fink G, Franz M, Carter G. Systemic
cytokine gene expression induced by pancreatitis.
Gastroenterology 1995; 108 (suppl A): 1226.
13. Norman J, Franz M, Riker A, et al. Rapid elevation of
pro-inflammatory cytokines during acute pancreatitis
and their origination within the pancreas. Surg Forum
(4, 15).
The inflammatory cytokine IL-6, on the other hand,
1
994; 45: 145–160.
is generated within the pancreas and its concentration
in the blood is associated with the degree of inflamma-
tion and pancreatic damage (12, 13). Previous studies
have shown that IL-6 values correlated well with the
severity of the disease (6, 7, 11). In the present study,
IL-6 plasma values at 6 hours and 24 hours, correlated
with the concentrations of taurocholate injected. The
two concentrations that we used also correlated with
the pathological score, and with the mortality, much
like the human form of the disease.
1
1
1
1
4. Paran H, Klausner J, Siegal A, et al. Effect of the
somatostatin analogue octreotide on experimental pan-
creatitis in rats. J Surg Res 1996; 62: 201–206.
5. Ranson JHC, Rifkind KM, Turner JW. Prognostic signs
and nonoperative peritoneal lavage in acute pancreatitis.
Surg Gynecol obstet 1976; 143: 209–219.
6. Schmidt J, Rattner DW, Lewandrowski K, et al. A better
model of acute pancreatitis for evaluating therapy. Ann
Surg 1992; 215: 44–56.
7. Steer ML. Workshop on experimental pancreatitis. Dig
Dis Sci 1985; 30: 575–581.
We conclude that this model of experimental
pancreatitis, by intraparenchymal injection in rats, is
simple and highly reproducible. It is suitable for the
investigation of acute pancreatitis, and will be useful in
studies of new methods of treatment.
Submitted August 9, 1999; submitted after revision January
7, 2000; accepted March 8, 2000
1
Address for correspondence:
Haim Paran, M.D.
Department Surgery “A”
Meir Hospital
REFERENCES
1
2
. Aho HJ, Nevalainen TJ, Aho AJ. Experimental pan-
creatitis in the rat. Eur Surg Res 1983; 15: 28–36.
. Bawni JB, Orda R, Wiznitzer T. Acute necrotizing
Kfar-Sava
Israel
Eur J Surg 166